Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · IEX Real-Time Price · USD
2.550
+0.220 (9.44%)
At close: May 31, 2024, 4:00 PM
2.640
+0.090 (3.53%)
After-hours: May 31, 2024, 5:49 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $17.83 million as of May 31, 2024. Its market cap has decreased by -51.14% in one year.
Market Cap
17.83M
Enterprise Value
-17.09M
1-Year Change
-51.14%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $17.83M, a decrease of -83.88%. That is a compound annual growth rate of -16.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2024 | 16.30M | -2.98% |
May 29, 2024 | 16.80M | -1.75% |
May 28, 2024 | 17.10M | - |
May 24, 2024 | 17.10M | -2.84% |
May 23, 2024 | 17.60M | 0.57% |
May 22, 2024 | 17.50M | 1.74% |
May 21, 2024 | 17.20M | -0.58% |
May 20, 2024 | 17.30M | -1.70% |
May 17, 2024 | 17.60M | -2.22% |
May 16, 2024 | 18.00M | - |
May 15, 2024 | 18.00M | 4.05% |
May 14, 2024 | 17.30M | 1.17% |
May 13, 2024 | 17.10M | 2.40% |
May 10, 2024 | 16.70M | -5.11% |
May 9, 2024 | 17.60M | - |
May 8, 2024 | 17.60M | 1.15% |
May 7, 2024 | 17.40M | 6.10% |
May 6, 2024 | 16.40M | -1.20% |
May 3, 2024 | 16.60M | 1.22% |
May 2, 2024 | 16.40M | -2.38% |
May 1, 2024 | 16.80M | 1.82% |
Apr 30, 2024 | 16.50M | -2.37% |
Apr 29, 2024 | 16.90M | -0.59% |
Apr 26, 2024 | 17.00M | - |
Apr 25, 2024 | 17.00M | -3.41% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vincerx Pharma | 18.64M |
Sensei Biotherapeutics | 18.55M |
Synlogic | 18.26M |
Lumos Pharma | 18.26M |
Purple Biotech | 18.15M |
Orgenesis | 17.74M |
VBI Vaccines | 17.57M |
Aytu BioPharma | 17.54M |